Advancing sustainable building technology

Kontrol Technologies Corp. (NEO: KNR) (OTCQB: KNRLF) (FSE: 1K8) ("Kontrol" or the "Company"), a leader in smart building technologies, has received an initial BioCloud order, following the signing of a  Memorandum of Understanding ("MOU") with an international heating, cooling and ventilation ("HVAC Company") on September 21^st, 2021. Kontrol and the HVAC Company continue to work towards a definitive distribution agreement and the potential of international manufacturing.  The HVAC company is part of large global industrial conglomerate which designs, manufactures, and distributes its proprietary products through more than 30,000 distributors globally. 

Steelcase Update

The Steelcase distributor launch is planned for mid October. To date initial training, marketing materials and product pages have been established.  Steelcase is a leading office technology solutions company and trades on the NYSE.    

Marshall Communications

BioCloud will be showcased in Washington, DC with Marshall Communications to support meetings and presentations to various Government and USA military officials on October 11^th, 2021.

"In a short period of time BioCloud has grown into a recognized air quality brand and as we launch with or strategic distribution and scaling partners, we look forward to being part of the solution for creating safer spaces," said Paul Ghezzi, CEO of Kontrol.

Carbon Credit Platform

Following the launch of its carbon credit platform the Company has received strong market feedback and is actively pursuing opportunities in Ontario, Quebec, Alberta and British Columbia as well as the Eastern United States.  Regions where the cost of energy is high and the where Local Utility Companies offer incentive rebates for energy savings are ideal markets.

"With a growing portfolio of technology solutions to address the important challenges our customers face,  including energy management, lower GHG emissions and improved air quality for the built environment, we are well positioned to continue to execute on our strategic vision," continues Ghezzi.

About Kontrol BioCloud^TM

Kontrol BioCloud ("BioCloud") is an operating subsidiary of Kontrol Technologies Corp. The BioCloud technology is a real-time analyzer designed to detect airborne viruses and pathogens. BioCloud is an air quality technology and not a medical device. BioCloud has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and a silent notification system is created. BioCloud can be applied to any space where individuals gather. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

About Kontrol Technologies Corp.

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com  and by reviewing its profile on SEDAR at www.sedar.com  

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. 

Where Kontrol expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking
statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all; that those technologies will not prove as effective as expected; those customers and potential customers will not be as accepting of the Company's product and service offering as expected; and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.  Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.